Common Shares |
7. Common Shares Equity Financing Vista is party to an at-the-market offering agreement (the “ATM Agreement”) with H. C. Wainwright & Co., LLC (“Wainwright”), under which the Company has the right, but is not obligated, to sell and issue common shares in the capital of the Company (each a “Common Share”) through Wainwright for aggregate gross proceeds of up to $10,000 (the “ATM Program”). During the three and nine months ended September 30, 2024, the Company realized net proceeds of $395 and $639, respectively, under the ATM Program. During the three and nine months ended September 30, 2023, the Company realized net proceeds of $nil and $1,013, respectively, under the ATM Program. As of September 30, 2024, $8,042 remained available under the ATM Program. Warrants Warrant activity is summarized in the following table. | | | | | | | | | | | | | Weighted | | Weighted | | | | | | Average | | Average | | | | Warrants | | Exercise Price | | Remaining Life | | | | Outstanding | | Per Share | | (Years) | | As of December 31, 2022 | | 7,408,101 | | $ | 1.25 | | 1.5 | | As of December 31, 2023 | | 7,408,101 | | $ | 1.25 | | 0.5 | | Expired | | (7,408,101) | | $ | 1.25 | | | | As of September 30, 2024 | | — | | | | | | |
All warrants expired on July 12, 2024. Stock-Based Compensation The Company’s active stock-based compensation plans include restricted share units (“RSUs”) issuable pursuant to the Company’s long-term equity incentive plan and deferred share units (“DSUs”) issuable pursuant to the Company’s deferred share unit plan (“DSU Plan”). The Company's stock option plan remains in place, however no new issuances can be made at this time. Stock-based compensation may be issued to our directors, officers, employees, and consultants. The maximum number of Common Shares that may be reserved for issuance under the combined stock-based compensation plans is a variable number equal to 10% of the issued and outstanding Common Shares on a non-diluted basis at any particular time. Stock-based compensation may be granted from time to time at the discretion of the Board of Directors of the Company (the “Board”), with vesting provisions as determined by the Board. Stock-based compensation expense was: | | | | | | | | | | | | | | | | Three Months Ended September 30, | | Nine Months Ended September 30, | | | | 2024 | | 2023 | | 2024 | | 2023 | | RSUs | | $ | 105 | | $ | 101 | | $ | 282 | | $ | 284 | | DSUs | | | — | | | — | | | 293 | | | 244 | | | | $ | 105 | | $ | 101 | | $ | 575 | | $ | 528 | |
As of September 30, 2024, unrecognized compensation expense for RSUs was $397, which is expected to be recognized over a weighted average period of 1.3 years. Restricted Share Units The following table summarizes RSU activity: | | | | | | | | | | | Weighted Average | | | | Number | | Grant-Date Fair | | | | of RSUs | | Value Per RSU | | Unvested - December 31, 2022 | | 1,472,008 | | $ | 0.60 | | Granted | | 1,163,000 | | | 0.37 | | Cancelled/forfeited | | (335,786) | | | 0.58 | | Vested, net of shares withheld | | (412,548) | | | 0.60 | | Unvested - December 31, 2023 | | 1,886,674 | | $ | 0.46 | | Granted | | 1,736,000 | | | 0.25 | | Cancelled/forfeited | | (409,450) | | | 0.50 | | Vested, net of shares withheld | | (445,551) | | | 0.59 | | Unvested - September 30, 2024 | | 2,767,673 | | $ | 0.30 | |
During the nine months ended September 30, 2024 and 2023, the Company withheld Common Shares with an equivalent value to meet employee withholding tax obligations of $85 and $142, respectively, which resulted from the vesting of RSUs during these periods. Common Shares withheld are considered cancelled/forfeited. Deferred Share Units The DSU Plan provides for granting of DSUs to non-employee directors. DSUs vest immediately; however, the Company will issue one Common Share for each DSU only when the non-employee director ceases to be a director of the Company. During the nine months ended September 30, 2024, the Board granted 767,000 DSUs and the Company recognized $293 in DSU expense. During the nine months ended September 30, 2023, the Board granted 420,000 DSUs and the Company recognized $244 in DSU expense. The following table summarizes DSU activity: | | | | | | | | | | | | | | | | | | | Weighted Average | | | | Number of | | | Grant-Date Fair | | | | DSUs | | | Value per DSU | | Outstanding - December 31, 2022 | | 1,254,000 | | $ | 0.72 | | Granted | | 420,000 | | | 0.58 | | Shares issued to participants | | (485,000) | | | 0.69 | | Outstanding - December 31, 2023 | | 1,189,000 | | $ | 0.68 | | Granted | | 767,000 | | | 0.38 | | Shares issued to participants | | (295,000) | | | 0.68 | | Outstanding - September 30, 2024 | | 1,661,000 | | $ | 0.54 | |
Stock Options The following table summarizes option activity for vested awards: | | | | | | | | | | | | | | | | | | Weighted Average | | | | | | | | Weighted Average | | Remaining | | Aggregate | | | | Number of | | Exercise Price | | Contractual Term | | Intrinsic | | | | Options | | Per Option | | (Years) | | Value | | Outstanding - December 31, 2022 | | 1,367,000 | | $ | 0.71 | | 0.64 | | $ | — | | Expired | | (967,000) | | | 0.71 | | | | | | | Outstanding - December 31, 2023 | | 400,000 | | $ | 0.70 | | 0.47 | | $ | — | | Expired | | (350,000) | | | 0.73 | | | | | | | Outstanding - September 30, 2024 | | 50,000 | | $ | 0.51 | | 0.50 | | $ | 13 | | | | | | | | | | | | | | Exercisable - September 30, 2024 | | 50,000 | | $ | 0.51 | | 0.50 | | $ | 13 | |
Weighted Average Common Shares | | | | | | | | | | | | Three Months Ended September 30, | | Nine Months Ended September 30, | | | | 2024 | | 2023 | | 2024 | | 2023 | | Basic Common Shares | | 122,341,829 | | 121,088,494 | | 121,829,163 | | 120,263,330 | | Effect of dilutive stock-based awards | | — | | — | | 3,245,228 | | — | | Diluted Common Shares | | 122,341,829 | | 121,088,494 | | 125,074,391 | | 120,263,330 | |
Unvested RSUs representing 100,668 Common Shares, stock options to purchase 400,000 Common Shares, and warrants to purchase 7,408,101 Common Shares were excluded from the computation of diluted earnings per share for the nine months ended September 30, 2024 because their effect would have been antidilutive. As the Company was in a net loss position for the three months ended September 30, 2024, and the three and nine months ended September 30, 2023, all potentially dilutive Common Shares were considered antidilutive.
|